Actaea racemosa 160 mg
30 coated tablets

MS: 1.1860.0007.

Actaea racemosa | Cimicifuga was recently reclassified as Actaea racemosa, first described by botanist Plunet in 1696 and later in the eighteenth century by Linné. The activity of Cimicifuga is demonstrated in studies with standardized extract of 2.5% total triterpenic glycosides (including 27-deoxyactein) .¹ Its traditionality is based on 40 years of clinical experience and also on investigations that have proven effective in alleviating symptoms related to the climacteric. Cimicifuga is a good choice for women approaching menopause, especially for those concerned about the potential risks of conventional therapy. Today, more than one and a half million Europeans consume Cimicifuga extracts for the purpose of attenuating hot flushes and depressive states.², ³

1 - Struck D, Tegtmeier M, Harnischfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Med .63:289-290.1997.
2 - Farnsworth et al. The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women’s Health: from plant to clinical use. Am J Clin Nutrr. 87(2): 504-8. 2008.
3 - Mello NK. Commentary on Black Cohosh for Treatment of Menopausal Disorders. Menopause. 2008; 15(5): 819-820